CellMax Life
People in the News at CellMax Life, Jackson Lab, BC Platforms, GeneDx
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of April 3, 2023.
The company believes the new results, from an initial prospective multisite trial, reflect what it can achieve in the larger cohort that it is now planning to recruit.
CellMax Life, Sebela Pharmaceuticals Sign Commercial Agreement for Colorectal Cancer Dx Test
CellMax also completed a Series C financing round to speed up development of itsFirstSight liquid biopsy test to detect colorectal cancer and precancer polyps.
Investigators reported on detection rates for cancers and precancers in a group of 350 individuals presenting for standard of care colonoscopy.
CellMax Life Highlights Liquid Biopsy Platform's Ability to Detect Pre-Cancer, Cancer
CellMax is developing and applying its CTC platform for early detection of colorectal cancer and more long term for breast and prostate cancer.
Jan 2, 2019